Alexander Johns

Chairman
Arete Strategies, LLC

Alexander Johns brings over two decades of bio-pharmastrategy consulting experience from industry leaders, including many of the themost successful launches, to start-up companies. Alexander earned his MBA fromthe University of Chicago in 1987 and joined Frank Lynn & Associates wherehe began bio-pharma strategy consulting in 1990. Alexander continued to expandhis biotech clientele as Founder & Principal at Quality Directions1991-1995 and then as Founder & Chairman of bioStrategies Group 1995-2011.Alexander now leads Areté Strategies as Founder & Chairman.

Check out the incredible speaker line-up to see who will be joining Alexander.

Download The Latest Agenda

Day 2

Sunday, April 10th, 2016

11:25 PANEL: Determining How Health Economics And Pricing Reimbursement Are Impacting Research Outcomes And Partnering Strategy

• Examining the current state of pricing reimbursement globally; what are the differences among Europe, the US, and other areas you work in?

• Explaining why health outcomes research so important to your potential partners; Will it continue to be a major driver?

• Debating whether health economics and research outcomes need to be incorporated into clinical trials no later than phase 2, and perhaps even in phase 1

• Establishing how health economic and research outcome data either drive value or cripple your opportunity for partnering